Nearly 50% of brand medicine spending goes to the supply chain and others

Nearly 50% of total spending on brand medicines – the sum of all payments made at the pharmacy or paid on a claim to a health care provider – went to the supply chain and other entities in 2018,...
Read More
New NHE data: Medicine prices declined, and hospitals were biggest driver of health care spending in 2018

According to new data from the National Health Expenditures (NHE), retail medicine prices declined by 1% and retail medicine spending grew just 2.5% in 2018. To put that in context, hospital...
Read More
Hospitals make 9 times more than physicians’ offices on provider-administered medicines

A new study, conducted by the Partnership for Health Analytic Research (PHAR), found that hospitals retained 91% of the total profit on physician-administered medicines in the commercial market that...
Read More
Fact Check: How hospitals continue to drive health care spending

There is a lot of talk about health care costs in the United States that is mostly centered on prescription medicine spending, overlooking the largest share of U.S. health care spending – hospital...
Read More
340B Spotlight: How for-profit middlemen are taking advantage of a program meant to support nonprofit entities and patients

Congress created the 340B program to help safety-net providers, like federally-funded safety net clinics, access discounts on prescription medicines for vulnerable or uninsured patients....
Read More
Study finds hospitals continue to mark up medicines up to 500% of their cost

A new analysis from the Moran Company found hospitals continue to charge, on average, five times their cost for medicines, driving up cost sharing and premiums for patients across the country. This...
Read More
Fresh data show, yet again, 340B is growing while charity care dwindles at many 340B hospitals

There has been broad acknowledgement in Congress and by the Administration, as well as by patient groups and some hospitals, that the 340B program is not working as Congress intended. Yet little has...
Read More
New study finds hospitals continue to push patients to costlier outpatient settings

A new study from the Health Care Cost Institute found that, for commercially insured patients, almost 50 percent of medicines administered by physicians, including treatments for diseases like...
Read More
340B continues to drive shift in site of care for physician-administered medicines to more expensive hospital settings

Is 340B benefiting the vulnerable, uninsured patients it was designed to help? Evidence continues to show otherwise. An updated analysis from Berkeley Research Group (BRG) is the latest to build on...
Read More
New study finds hospitals prescribe more medicines, and more expensive medicines, after joining 340B program

Data and analyses continue to show the 340B program influences prescribing trends at 340B hospitals – ultimately costing patients and our health care system more money. The Government Accountability...
Read More